CSL (ASX:CSL) update their R&D

04DecDecember 4, 2019

Biotech company CSL (ASX:CSL) is advancing its Research & Development (R&D) pipeline and capabilities to deliver a highly differentiated product portfolio mix, addressing a broader range of patients’ unmet needs.

During their annual R&D briefing to investors it was noted that the company is building on its leadership in plasma therapies through the identification of emerging new medicines.

They are collaborating with universities across the globe and have over 1,700 scientists working on therapies for challenging medical conditions.

In FY19, CSL invested US$832 million into its R&D portfolio, representing 9.7% of total revenues.

Shares in CSL (ASX:CSL) are trading 0.9 per cent lower at $275.38.

Copyright 2019 – Finance News Network

Source: Finance News Network

24MayMay 24, 2022

Snap dives 28% pulling ASX tech giants lower on rising inflation

24 May 2022 - Snap’s share price dived over 28% after an earnings miss, warning investors of a hiring slowdown with the Nasdaq futures falling 1.3% as investors fret about tech giant’s reliance on internet advertising. The news pulled Facebook-owner Meta Platforms and Google-owner Alphabet down 7 and almost 4% respectively.

03OctOctober 3, 2019

Clean Seas Seafood delays opening of Queensland farm

03 Oct 2019 - Clean Seas Seafood (ASX:CSS) has to delay the opening of its new farm at Fitzgerald Bay, near Whyalla in Queensland.

16NovNovember 16, 2020

ClearVue Technologies Limited (ASX:CPV) start work on clear solar glass greenhouse

16 Nov2020 - Smart building materials company ClearVue Technologies Limited (ASX:CPV) reports that work has started on the CRC-P grant funded greenhouse on Murdoch University land.

24SepSeptember 24, 2020

Washington H. Soul Pattinson and Company (ASX:SOL) report dividend growth

24 Sep 2020 - Diversified investment house, Washington H. Soul Pattinson and Company (ASX:SOL) report a regular net profit after tax of $169.8 million for the year, down 45 per cent on the previous corresponding period.

18SepSeptember 18, 2019

Link Market Services build partnership with OFX Group

18 Sep 2019 - OFX Group (ASX:OFX) today announced an exclusive strategic partnership with Link Market Services (ASX:LNK), where OFX will become Link’s preferred partner in Australia for international payments such as dividends and corporate action payments on Link’s Investor Centre platform.